PLMA_1170x120_10-8-21

second quarter

CVS’ Q2 sales and earnings beat forecasts

CVS’ Q2 sales and earnings beat forecasts

WOONSOCKET, R.I. — CVS Health posted second quarter sales and earnings that easily topped analysts’ projections. Strong retail sales helped lift the company’s adjusted profit to $2.42 a share, well ahead of Wall Street’s prediction of $2.07 a share. Revenue climbed 11.1% to $72.62 billion, beating the forecast of $70.24 billion. The company boosted its

WBA’s Q2 earnings top forecast

WBA’s Q2 earnings top forecast

DEERFIELD, Ill. _  Walgreens Boots Alliance’s second quarter earnings easily beat analysts’ projections, as sales rose 4.6% to $32.8 billion. WBA posted adjusted earnings of $1.21 billion, or $1.40 per share, well ahead of Wall Street’s estimate of $1.11. The company elevated its full year guidance to mid-to-high single digit growth in constant currency adjusted

Rite Aid’s Q2 sales and earnings top projections

Rite Aid’s Q2 sales and earnings top projections

CAMP HILL, Pa. — Rite Aid’s second quarter sales and earnings beat Wall Street’s forecast. Adjusted earnings per share of 25 cents topped analysts’ projection of a 1 cent loss.  Revenue for the period ended August 29 climbed 11.5% to $5.98 billion, driven by store and PBM gains, and bettering the forecast $5.75 billion. The

Sales rise in 2Q at Walgreens Boots Alliance

Sales rise in 2Q at Walgreens Boots Alliance

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) reported double-digit revenue growth for its fiscal 2016 second quarter, with adjusted earnings per share topping Wall Street’s consensus forecast. WBA said Tuesday that second-quarter sales climbed 13.6% to $30.18 billion from $26.57 billion a year earlier. The gain stemmed largely from the full consolidation of Alliance Boots

CVS Health tallies 2Q sales, earnings gains

CVS Health tallies 2Q sales, earnings gains

WOONSOCKET, R.I. — CVS Health saw sales climb in the second quarter and posted adjusted earnings per share in line with Wall Street’s forecast, despite the impact of costs from its pending Omnicare and Target pharmacy acquisitions. CVS said Tuesday that for the three months ended June 30, total sales rose 7.4% to $37.2 billion from